{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T19:06:34Z","timestamp":1775243194558,"version":"3.50.1"},"reference-count":80,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice & Research Clinical Gastroenterology"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.bpg.2010.10.004","type":"journal-article","created":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T09:49:35Z","timestamp":1291196975000},"page":"923-936","source":"Crossref","is-referenced-by-count":46,"title":["An algorithm for diagnosis and treatment of refractory GERD"],"prefix":"10.1016","volume":"24","author":[{"given":"Tiberiu","family":"Hershcovici","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronnie","family":"Fass","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpg.2010.10.004_bib1","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1111\/j.1572-0241.2003.07665.x","article-title":"Step-down from multiple- to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs","volume":"98","author":"Inadomi","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2010.10.004_bib2","series-title":"The 2000 Gallup study of consumers\u2019 use of stomach relief products","author":"Gallup Organization","year":"2000"},{"key":"10.1016\/j.bpg.2010.10.004_bib3","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/S1542-3565(04)00288-5","article-title":"Effectiveness of proton pump inhibitors in nonerosive reflux disease","volume":"2","author":"Dean","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2010.10.004_bib4","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1185\/03007990903035745","article-title":"Treatment patterns and symptom control in patients with GERD: US community-based survey","volume":"25","author":"Chey","year":"2009","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.bpg.2010.10.004_bib5","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2165\/00003495-200363060-00003","article-title":"Barrett\u2019s oesophagus: optimal strategies for prevention and treatment","volume":"63","author":"Fass","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.bpg.2010.10.004_bib6","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1136\/gut.2007.145581","article-title":"Management of heartburn not responding to proton pump inhibitors","volume":"58","author":"Fass","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2010.10.004_bib7","series-title":"The functional gastrointestinal disorders","author":"Rome","year":"2006"},{"key":"10.1016\/j.bpg.2010.10.004_bib8","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.cgh.2008.02.016","article-title":"Persistent heartburn in a patient on proton-pump inhibitor","volume":"6","author":"Fass","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2010.10.004_bib9","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s11894-008-0052-5","article-title":"Refractory GERD: what is it?","volume":"10","author":"Fass","year":"2008","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.bpg.2010.10.004_bib10","first-page":"463","article-title":"Factors influencing compliance in long-term proton pump inhibitor therapy in general practice","volume":"49","author":"Hungin","year":"1999","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.bpg.2010.10.004_bib11","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1111\/j.1365-2036.2006.02911.x","article-title":"Sub-optimal proton pump inhibitor dosing is prevalent in patients with poorly controlled gastro-oesophageal reflux disease","volume":"23","author":"Gunaratnam","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.bpg.2010.10.004_bib12","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/j.1572-0241.2008.01791.x","article-title":"Characteristics of symptomatic reflux episodes on acid suppressive therapy","volume":"103","author":"Tutuian","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2010.10.004_bib13","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1136\/gut.2007.133470","article-title":"Determinants of gastro-oesophageal reflux perception in patients with persistent symptoms despite proton pump inhibitors","volume":"57","author":"Zerbib","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2010.10.004_bib14","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1365-2982.2007.01028.x","article-title":"Oesophageal tone and sensation in the transition zone between proximal striated and distal smooth muscle oesophagus","volume":"20","author":"Karamanolis","year":"2008","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.bpg.2010.10.004_bib15","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.gie.2007.05.027","article-title":"Role of endoscopy in the management of GERD","volume":"66","author":"Lichtenstein","year":"2007","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.bpg.2010.10.004_bib16","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.gie.2009.08.024","article-title":"Upper GI tract findings in patients with heartburn in whom proton pump inhibitor treatment failed versus those not receiving antireflux treatment","volume":"71","author":"Poh","year":"2010","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.bpg.2010.10.004_bib17","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/0016-5085(88)90162-X","article-title":"Healing and relapse of severe peptic esophagitis after treatment with omeprazole","volume":"95","author":"Hetzel","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2010.10.004_bib18","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0016-5085(92)91790-B","article-title":"Two doses of omeprazole versus placebo in symptomatic erosive esophagitis: the U.S. Multicenter Study","volume":"102","author":"Sontag","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2010.10.004_bib19","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/ncpgasthep0979","article-title":"How to manage refractory GERD","volume":"4","author":"Richter","year":"2007","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2010.10.004_bib20","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.cgh.2006.08.006","article-title":"Microscopic esophageal mucosal injury in nonerosive reflux disease","volume":"5","author":"Dent","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2010.10.004_bib21","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1007\/s10620-005-2960-7","article-title":"The value of ambulatory 24\u00a0h esophageal pH monitoring in clinical practice in patients who were referred with persistent gastroesophageal reflux disease (GERD)-related symptoms while on standard dose anti-reflux medications","volume":"50","author":"Bautista","year":"2005","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.bpg.2010.10.004_bib22","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/j.1572-0241.2006.00936.x","article-title":"ACG practice guidelines: esophageal reflux testing","volume":"102","author":"Hirano","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2010.10.004_bib23","first-page":"1532","article-title":"Optimal dosing of omeprazole 40 mg daily: effects on gastric and esophageal pH and serum gastrin in healthy controls","volume":"91","author":"Kuo","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2010.10.004_bib24","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1023\/A:1026608804938","article-title":"Effect of ambulatory 24-hour esophageal pH monitoring on reflux-provoking activities","volume":"44","author":"Fass","year":"1999","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.bpg.2010.10.004_bib25","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1572-0241.2005.41210.x","article-title":"The role of esophageal pH monitoring in symptomatic patients on PPI therapy","volume":"100","author":"Charbel","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2010.10.004_bib26","first-page":"2387","volume":"53","author":"Karamanolis","year":"2008","journal-title":"Yield of 24-hour esophageal pH and Bilitec monitoring in patients with persisting symptoms on PPI therapy"},{"key":"10.1016\/j.bpg.2010.10.004_bib27","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1111\/j.1572-0241.2001.03863.x","article-title":"The role of acid and duodenal gastroesophageal reflux in symptomatic GERD","volume":"96","author":"Koek","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2010.10.004_bib28","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1136\/gut.2005.087668","article-title":"Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring","volume":"55","author":"Mainie","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2010.10.004_bib29","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.cgh.2008.01.006","article-title":"An analysis of persistent symptoms in acid-suppressed patients undergoing impedance-pH monitoring","volume":"6","author":"Sharma","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2010.10.004_bib30","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S1542-3565(05)00529-X","article-title":"Bravo pH capsule monitoring with and without proton pump inhibitor therapy","volume":"3","author":"Hirano","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2010.10.004_bib31","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1136\/gut.2003.033290","article-title":"Gastro-oesophageal reflux monitoring: review and consensus report on detection and definitions of acid, non-acid, and gas reflux","volume":"53","author":"Sifrim","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2010.10.004_bib32","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1053\/gast.2001.24840","article-title":"Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole","volume":"120","author":"Vela","year":"2001","journal-title":"Gastroenterology"},{"issue":"#925","key":"10.1016\/j.bpg.2010.10.004_bib33","first-page":"A-130","article-title":"Reflux symptoms on twice daily (BID) proton pump inhibitor (PPI) associated with non acid reflux; a manifestation of hypersensitive esophagus?","volume":"128","author":"Katz","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2010.10.004_bib34","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1111\/j.1572-0241.2006.00711.x","article-title":"Esophageal pH-impedance monitoring and symptom analysis in GERD: a study in patients off and on therapy","volume":"101","author":"Zerbib","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2010.10.004_bib35","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1080\/00365520701245645","article-title":"Biliary reflux and non-acid reflux are two distinct phenomena: a comparison between 24-hour multichannel intraesophageal impedance and bilirubin monitoring","volume":"42","author":"Pace","year":"2007","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.bpg.2010.10.004_bib36","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s10620-005-1282-0","article-title":"Esophageal visceral sensitivity to bile salts in patients with functional heartburn and in healthy control subjects","volume":"50","author":"Siddiqui","year":"2005","journal-title":"Dig Dis Sci"},{"issue":"#S1897","key":"10.1016\/j.bpg.2010.10.004_bib37","first-page":"A-274","article-title":"Weakly acidic solutions containing pepsin and bile acids can increase significantly esophageal mucosa permeability","volume":"132","author":"Farre","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2010.10.004_bib38","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/j.1572-0241.2004.04171.x","article-title":"Gastroesophageal reflux disease poorly responsive to single-dose proton pump inhibitors in patients without Barrett\u2019s esophagus: acid reflux, bile reflux, or both?","volume":"99","author":"Tack","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2010.10.004_bib39","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1038\/ajg.2009.240","article-title":"Comparison of the degree of duodenogastroesophageal reflux and acid reflux between patients who failed to respond and those who were successfully treated with a proton pump inhibitor once daily","volume":"104","author":"Gasiorowska","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2010.10.004_bib40","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/0016-5085(94)90123-6","article-title":"Duodenogastroesophageal reflux: relationship to pH and importance in Barrett\u2019s esophagus","volume":"107","author":"Champion","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2010.10.004_bib41","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1046\/j.1365-2036.2001.01069.x","article-title":"Esophageal visceral sensitivity to bile salts in patients with functional heartburn and in healthy control subjects","volume":"15","author":"Netzer","year":"2001","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.bpg.2010.10.004_bib42","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/j.1365-2036.2005.02406.x","article-title":"Normalization of oesophageal pH does not guarantee control of duodenogastro-oesophageal reflux in Barrett\u2019s oesophagus","volume":"21","author":"Todd","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.bpg.2010.10.004_bib43","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1136\/gut.52.10.1397","article-title":"Effect of the GABA(B) agonist baclofen in patients with symptoms and duodeno-gastro-oesophageal reflux refractory to proton pump inhibitors","volume":"52","author":"Koek","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2010.10.004_bib44","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.2165\/00003495-200767110-00001","article-title":"Proton-pump inhibitor therapy in patients with gastro-oesophageal reflux disease: putative mechanisms of failure","volume":"67","author":"Fass","year":"2007","journal-title":"Drugs"},{"key":"10.1016\/j.bpg.2010.10.004_bib45","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1001\/archinte.166.9.965","article-title":"Are lifestyle measures effective in patients with gastroesophageal reflux disease? An evidence-based approach","volume":"166","author":"Kaltenbach","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.bpg.2010.10.004_bib46","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/S0016-5085(98)70010-1","article-title":"Ranitidine controls nocturnal gastric acid breakthrough on omeprazole: a controlled study in normal subjects","volume":"115","author":"Peghini","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2010.10.004_bib47","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1053\/gast.2002.31876","article-title":"Long-term effect of H2RA therapy on nocturnal gastric acid breakthrough","volume":"122","author":"Fackler","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2010.10.004_bib48","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1097\/MCG.0b013e31814a4e5c","article-title":"Addition of a H2 receptor antagonist to PPI improves acid control and decreases nocturnal acid breakthrough","volume":"42","author":"Mainie","year":"2008","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.bpg.2010.10.004_bib49","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1442-2050.2005.00518.x","article-title":"Histamine-2 receptor antagonists at night improve gastroesophageal reflux disease symptoms for patients on proton pump inhibitor therapy","volume":"18","author":"Rackoff","year":"2005","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.bpg.2010.10.004_bib50","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1053\/j.gastro.2008.08.045","article-title":"American Gastroenterological Association medical position statement on the management of gastroesophageal reflux disease","volume":"135","author":"Kahrilas","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2010.10.004_bib51","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006036.pub2","article-title":"Medical treatments in the short term management of reflux oesophagitis","author":"Khan","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bpg.2010.10.004_bib52","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S1542-3565(05)00860-8","article-title":"Treatment of patients with persistent heartburn symptoms: a double-blind, randomized trial","volume":"4","author":"Fass","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2010.10.004_bib53","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1046\/j.1365-2036.1998.00426.x","article-title":"Nocturnal gastric acidity and acid breakthrough on different regimens of omeprazole 40 mg daily","volume":"12","author":"Hatlebakk","year":"1998","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.bpg.2010.10.004_bib54","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.dld.2007.01.023","article-title":"Efficacy in intra-oesophageal acid suppression may decrease after 2-year continuous treatment with proton pump inhibitors","volume":"39","author":"Frazzoni","year":"2007","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.bpg.2010.10.004_bib55","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.dld.2006.06.002","article-title":"Acid-suppressive effects of rabeprazole: comparing 10mg and 20mg twice daily in Japanese Helicobacter pylori-negative and -positive CYP2C19 extensive metabolisers","volume":"38","author":"Shimatani","year":"2006","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.bpg.2010.10.004_bib56","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/j.1365-2036.2009.03933.x","article-title":"Clinical trials: healing of erosive oesophagitis with dexlansoprazole MR, a proton pump inhibitor with a novel dual delayed-release formulation\u2013results from two randomized controlled studies","volume":"29","author":"Sharma","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.bpg.2010.10.004_bib57","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1111\/j.1365-2036.2009.04013.x","article-title":"Clinical trial: the effects of the proton pump inhibitor dexlansoprazole MR on daytime and nighttime heartburn in patients with non-erosive reflux disease","volume":"29","author":"Fass","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.bpg.2010.10.004_bib58","first-page":"G311","article-title":"Receptors and transmission in the brain-gut axis: potential for novel therapies. IV. GABA(B) receptors in the brain-gastroesophageal axis","volume":"281","author":"Blackshaw","year":"2001","journal-title":"Am J Physiol"},{"key":"10.1016\/j.bpg.2010.10.004_bib59","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1053\/j.gastro.2005.06.069","article-title":"Inhibition of transient lower esophageal sphincter relaxation and gastroesophageal reflux by metabotropic glutamate receptor ligands","volume":"129","author":"Frisby","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2010.10.004_bib60","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/gut.50.1.19","article-title":"Control of transient lower oesophageal sphincter relaxations and reflux by the GABA(B) agonist baclofen in patients with gastro-oesophageal reflux disease","volume":"50","author":"Zhang","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2010.10.004_bib61","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0016-5085(00)70408-2","article-title":"Control of transient lower esophageal sphincter relaxations and reflux by the GABA(B) agonist baclofen in normal subjects","volume":"118","author":"Lidums","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2010.10.004_bib62","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jpeds.2006.05.029","article-title":"Effect of baclofen on esophagogastric motility and gastroesophageal reflux in children with gastroesophageal reflux disease: a randomized controlled trial","volume":"149","author":"Omari","year":"2006","journal-title":"J Pediatr"},{"key":"10.1016\/j.bpg.2010.10.004_bib63","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1046\/j.1365-2036.2003.01394.x","article-title":"Baclofen decreases acid and non-acid post-prandial gastro-oesophageal reflux measured by combined multichannel intraluminal impedance and pH","volume":"17","author":"Vela","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.bpg.2010.10.004_bib64","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1124\/jpet.108.149773","article-title":"Arbaclofen placarbil, a novel R-baclofen prodrug: improved absorption, distribution, metabolism, and elimination properties compared with R-baclofen","volume":"330","author":"Lal","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bpg.2010.10.004_bib65","article-title":"Arbaclofen placarbil decreases postprandial reflux in patients with gastroesophageal reflux disease","author":"Gerson","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2010.10.004_bib66","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1053\/j.gastro.2010.04.051","article-title":"Effects of lesogaberan on reflux and lower esophageal sphincter function in patients with gastroesophageal reflux disease","volume":"139","author":"Boeckxstaens","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2010.10.004_bib67","first-page":"A436-A","article-title":"Efficacy and tolerability of the novel reflux inhibitor, AZD3355, as add-on treatment in GERD patients with symptoms despite proton pump inhibitor therapy","volume":"136","author":"Boeckxstaens","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2010.10.004_bib68","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1136\/gut.2008.162040","article-title":"A proof-of-concept study evaluating the effect of ADX10059, a metabotropic glutamate receptor-5 negative allosteric modulator, on acid exposure and symptoms in gastro-oesophageal reflux disease","volume":"58","author":"Keywood","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2010.10.004_bib69","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-2036.2005.02531.x","article-title":"Systematic review: proton-pump inhibitor failure in gastro-oesophageal reflux disease\u2013where next?","volume":"22","author":"Fass","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.bpg.2010.10.004_bib70","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/00004836-199904000-00008","article-title":"Antidepressant treatment of patients with diffuse esophageal spasm: a psychosomatic approach","volume":"28","author":"Handa","year":"1999","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.bpg.2010.10.004_bib71","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/0016-5085(87)90979-6","article-title":"Low-dose trazodone for symptomatic patients with esophageal contraction abnormalities. A double-blind, placebo-controlled trial","volume":"92","author":"Clouse","year":"1987","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2010.10.004_bib72","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1007\/s10620-007-0187-5","article-title":"Pyloric injection of botulinum toxin for the treatment of refractory GERD accompanied with gastroparesis: a preliminary report","volume":"53","author":"Mirbagheri","year":"2008","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.bpg.2010.10.004_bib73","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0016-5107(05)00328-7","article-title":"Endoscopic pyloric injection of botulinum toxin A for the treatment of refractory gastroparesis","volume":"61","author":"Bromer","year":"2005","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.bpg.2010.10.004_bib74","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1089\/lap.2006.16.557","article-title":"Laparoscopic antireflux surgery: long-term outcomes and quality of life","volume":"16","author":"Rosenthal","year":"2006","journal-title":"J Laparosc Adv Surg Tech A"},{"key":"10.1016\/j.bpg.2010.10.004_bib75","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1002\/bjs.5493","article-title":"Combined multichannel intraluminal impedance-pH monitoring to select patients with persistent gastro-oesophageal reflux for laparoscopic Nissen fundoplication","volume":"93","author":"Mainie","year":"2006","journal-title":"Br J Surg"},{"key":"10.1016\/j.bpg.2010.10.004_bib76","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1111\/j.1365-2036.2007.03529.x","article-title":"Clinical trial: persistent gastro-oesophageal reflux symptoms despite standard therapy with proton pump inhibitors - a follow-up study of intraluminal-impedance guided therapy","volume":"26","author":"Becker","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.bpg.2010.10.004_bib77","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1007\/s11605-008-0583-y","article-title":"Prospective assessment of patient selection for antireflux surgery by combined multichannel intraluminal impedance pH monitoring","volume":"12","author":"del Genio","year":"2008","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.bpg.2010.10.004_bib78","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/j.1365-2036.2007.03520.x","article-title":"Clinical trial: acupuncture vs. doubling the proton pump inhibitor dose in refractory heartburn","volume":"26","author":"Dickman","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.bpg.2010.10.004_bib79","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1365-2036.2007.03393.x","article-title":"Oesophageal hypersensitivity is associated with features of psychiatric disorders and the irritable bowel syndrome","volume":"26","author":"Rubenstein","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.bpg.2010.10.004_bib80","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1365-2036.2008.03596.x","article-title":"The influence of co-morbid IBS and psychological distress on outcomes and quality of life following PPI therapy in patients with gastro-oesophageal reflux disease","volume":"27","author":"Nojkov","year":"2008","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Best Practice & Research Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691810001393?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691810001393?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T13:26:21Z","timestamp":1544102781000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521691810001393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":80,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S1521691810001393"],"URL":"https:\/\/doi.org\/10.1016\/j.bpg.2010.10.004","relation":{},"ISSN":["1521-6918"],"issn-type":[{"value":"1521-6918","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}